Latest filing published 31 Mar 2026 for CELLECTIS. Read the official filing
No signal scores available.
All filings by Kyung Nam-Wortman on record concern Cellectis, in the capacity of senior executive. In total, 2 filings cover trades dated from 3 March 2025 to 24 May 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 31 March 2026, reports a share grant in Cellectis. Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations